Updated dailyPubMed-sourced · Research, not medical advice
PeptideResearchNewsScience · Studies · Signal
Breaking News

Case Series Shows Possible Link Between Semaglutide, Ophthalmic Complications - The American Journal of Managed Care® (AJMC®)

August 8, 2026Source: Google News - GLP-1 / Metabolic

Peptide Research News surfaces this story from Google News - GLP-1 / Metabolic. Read the complete article at the original source:

Read the full article at Google News - GLP-1 / Metabolic →

You Might Also Like

Novo Nordisk to be watchful on Semaglutide price erosion; expects to maintain Pill momentum in Obesity - ET Pharma
Breaking News

Novo Nordisk to be watchful on Semaglutide price erosion; expects to maintain Pill momentum in Obesity - ET Pharma

Delhi HC allows Sun Pharma to export semaglutide, restricts sale in India - Business Standard
Breaking News

Delhi HC allows Sun Pharma to export semaglutide, restricts sale in India - Business Standard

Natco Pharma Clarifies Semaglutide Partnership with Eris Lifesciences - scanx.trade
Breaking News

Natco Pharma Clarifies Semaglutide Partnership with Eris Lifesciences - scanx.trade

South Africa regulator reviews 12 generic semaglutide applications - The Mighty 790 KFGO
Breaking News

South Africa regulator reviews 12 generic semaglutide applications - The Mighty 790 KFGO

SkinnyRx GLP-1 Claims Evaluated: Review Semaglutide & Tirzepatide Weight Loss Medication Options with Clinician-Guided Care - BioSpace
Breaking News

SkinnyRx GLP-1 Claims Evaluated: Review Semaglutide & Tirzepatide Weight Loss Medication Options with Clinician-Guided Care - BioSpace

Lupin and Galenicum Sign License and Supply Agreement for Semaglutide in 23 Countries - Lupin | Press Release - lupin.com
Breaking News

Lupin and Galenicum Sign License and Supply Agreement for Semaglutide in 23 Countries - Lupin | Press Release - lupin.com

Tirzepatide a product with strong market and superior science, says Cipla CEO - ET Pharma
Breaking News

Tirzepatide a product with strong market and superior science, says Cipla CEO - ET Pharma

Dr. Reddy’s weight-loss drug Semaglutide rollout in Canada suffers setback - The Hindu
Breaking News

Dr. Reddy’s weight-loss drug Semaglutide rollout in Canada suffers setback - The Hindu